HypoAD atlas maps hypothalamus changes in aging and Alzheimer’s


MRI scans of 458 adults linked different hypothalamic regions to opposing changes with age, while a separate cell atlas found inflammatory and sleep-related gene activity associated with Alzheimer’s.
Researchers have created HypoAD, an atlas of changes in the human hypothalamus associated with aging and Alzheimer’s disease. The study, published in Nature on 18 November 2026, combines MRI analysis with a separate map of gene activity in donated brain tissue.
The hypothalamus helps regulate sleep, daily rhythms and metabolism, which can be disrupted alongside the cognitive symptoms of Alzheimer’s. Research has traditionally focused more on brain regions associated with memory, leaving the hypothalamus and its distinct cell types less well understood.
The MRI analysis drew on 458 adults in the Adult Metabolism & Brain Resilience and Connectomics in Brain Aging and Dementia studies. The lateral hypothalamus was smaller at older ages, while several other regions were larger. These associations remained in a model accounting for age, sex, cognitive and amyloid-β status and their interaction, intracranial volume and study cohort, using complete covariate data from 316 participants; amyloid-β is a protein that forms plaques in Alzheimer’s.
The regions associated with larger volumes included the suprachiasmatic nucleus, which coordinates daily rhythms, and the arcuate nucleus, which helps regulate appetite and energy balance. The paraventricular, periventricular and dorsomedial nuclei also showed that association.
The team also saw volume differences between people classified as having Alzheimer’s and similarly aged people without it, but those differences did not reach statistical significance. Measurements of several small structures, including the suprachiasmatic nucleus and mammillary body, which contributes to memory processing, were not consistently reproduced on repeat scans, so their estimated volumes require caution.

The gene-expression atlas measured which genes were active in 614,403 nuclei from 17 post-mortem donors. Researchers sequenced tissue from seven donors with mostly early-stage Alzheimer’s and seven age-matched controls, then added published data from three younger donors. One donor with familial Alzheimer’s was excluded from analyses comparing differences between groups.
The analysis found a pattern of gene activity associated with inflammation in microglia, immune cells of the central nervous system. It also found pronounced changes in inhibitory neurons, which can reduce signaling by other neurons, in regions involved in sleep and daily rhythms. Machine-learning models identified inflammation and regulators of daily rhythms among the features that distinguished Alzheimer’s cells from controls.
The imaging and tissue samples came from different people, and the newly sequenced donor group was small. The study compared people at a single point rather than following changes over time, so its findings show associations rather than cause and effect.
HypoAD is available to researchers studying hypothalamic changes. Senior author Ashley Webb, an associate professor at the Buck Institute for Research on Aging, said the team wants to follow those changes over time and test whether protecting the brain’s daily clock and neuropeptide signaling in particular can slow disease or help manage symptoms.
Measurements of metallic europium monosilicide revealed a spin pattern consistent with a predicted magnetic state. Neutron diffraction found the relevant spiral phase between about 33.4 K and 62 K, giving researchers a material in which to investigate it.
3 min

The study found a regional score of 0.73 in traditional jungle rubber agroforests, 20% below forest but higher than in rubber and oil palm monocultures.
2 min

The newly described viruses occur mainly in human and animal digestive systems. Researchers propose that their ancestors may help explain how poxviruses came to infect animal cells.
3 min